These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26376316)

  • 1. Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013.
    Tan T; Dalby T; Forsyth K; Halperin SA; Heininger U; Hozbor D; Plotkin S; Ulloa-Gutierrez R; Wirsing von König CH
    Pediatr Infect Dis J; 2015 Sep; 34(9):e222-32. PubMed ID: 26376316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing pertussis epidemiology: everything old is new again.
    Clark TA
    J Infect Dis; 2014 Apr; 209(7):978-81. PubMed ID: 24626532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology.
    Pesco P; Bergero P; Fabricius G; Hozbor D
    Epidemics; 2014 Jun; 7():13-21. PubMed ID: 24928665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis: pertussis control strategies and the options for improving current vaccines.
    Plotkin SA
    Expert Rev Vaccines; 2014 Sep; 13(9):1071-2. PubMed ID: 25090359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global pertussis initiative: Meeting report from the Regional Latin America Meeting, Costa Rica, 5-6 December, 2008.
    Ulloa-Gutierrez R; Hozbor D; Avila-Aguero ML; Caro J; Wirsing von König CH; Tan T; Plotkin S
    Hum Vaccin; 2010 Nov; 6(11):876-80. PubMed ID: 20980794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.
    Campbell PT; McCaw JM; McIntyre P; McVernon J
    Vaccine; 2015 Oct; 33(43):5794-5800. PubMed ID: 26392008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible options for new pertussis vaccines.
    Meade BD; Plotkin SA; Locht C
    J Infect Dis; 2014 Apr; 209 Suppl 1():S24-7. PubMed ID: 24626868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-emergence of pertussis: what are the solutions?
    Libster R; Edwards KM
    Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-emergence of diphtheria and pertussis: implications for Nigeria.
    Sadoh AE; Oladokun RE
    Vaccine; 2012 Nov; 30(50):7221-8. PubMed ID: 23102975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Global pertussis epidemiology and immunization strategies].
    Zhang WH
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):467-72. PubMed ID: 20084979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pertussis vaccine. Reemergence of the disease and new vaccination strategies].
    Moraga-Llop FA; Campins-Martí M
    Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):190-6. PubMed ID: 25707329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.
    Burns DL; Meade BD; Messionnier NE
    J Infect Dis; 2014 Apr; 209 Suppl 1():S32-5. PubMed ID: 24626870
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013.
    Heininger U; André P; Chlibek R; Kristufkova Z; Kutsar K; Mangarov A; Mészner Z; Nitsch-Osuch A; Petrović V; Prymula R; Usonis V; Zavadska D
    PLoS One; 2016; 11(6):e0155949. PubMed ID: 27257822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
    van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
    Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis in Africa: Findings and recommendations of the Global Pertussis Initiative (GPI).
    Muloiwa R; Wolter N; Mupere E; Tan T; Chitkara AJ; Forsyth KD; von König CW; Hussey G
    Vaccine; 2018 Apr; 36(18):2385-2393. PubMed ID: 29602703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis re-emergence in the post-vaccination era.
    Chiappini E; Stival A; Galli L; de Martino M
    BMC Infect Dis; 2013 Mar; 13():151. PubMed ID: 23530907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whooping cough, twenty years from acellular vaccines introduction.
    Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A
    Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.